Novartis tem despesas de US$ 2,2 bilhões após fracassos em testes clínicos

Folha de S.Paulo27 October 2026, 14:09 UTCUnited States of America

A Novartis registrou cerca de US$ 2,2 bilhões (R$ 11,88 bilhões) em despesas relacionadas a dois medicamentos que fracassaram em estudos de fase avançada no mês passado, mesmo tendo elevado suas projeções de lucro para o ano inteiro na terça-feira (27). Leia mais (10/27/2026 - 11h09)

Read the full story at Folha de S.Paulo Open in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about United States of America

¿Se puede remontar un 3-0? Aranda y los Tampa Bay Rays van por el milagro en la Serie Mundial pese a tener a la historia en contraInfobae Americas27 October 2026, 15:26 UTCUnited States of AmericaEl conjunto de Florida no ha tenido respuesta ante el ataque de los Milwaukee Brewers quienes llegaron a esta final de campeonato como los favoritos
Trump returns to Texas for a high-stakes push to keep the state in Republican handsWinnipeg Free Press27 October 2026, 15:20 UTCUnited States of AmericaGovernment leaders
Глава МИД РФ назвал дизельную сделку с США чисто деловой договоренностьюInterfax RU27 October 2026, 15:20 UTCUnited States of America
Boston Scientific earnings loom with cyberattack impact on deckInvesting.com27 October 2026, 15:19 UTCUnited States of AmericaCyber attacks
La cantante Alaska reconoce que le tienta la idea de una serie sobre su vidaInfobae Americas27 October 2026, 15:18 UTCUnited States of America
El FBI entra en mansión en California en investigación a excongresista por agresión sexualInfobae Americas27 October 2026, 15:15 UTCUnited States of America
Esto dicen las encuestas a una semana de las elecciones legislativas de Estados UnidosInfobae Americas27 October 2026, 15:15 UTCUnited States of America
Enterprises Empower AI Agents for Bounded TasksBusiness Wire27 October 2026, 15:15 UTCUnited States of AmericaSTAMFORD, Conn.--(BUSINESS WIRE)---- $III #AI--Enterprises are using agentic AI to redistribute work between people and machines, giving it defined operational responsibilities, ISG says.